Last reviewed · How we verify
NCT05054270
Efficacy of Lung Ultrasound in Monitoring Fluid Resuscitation in Chest Trauma Patients
trial testing Chest examination with Ultrasound device in Contusions Pulmonary in 100 participants. Completed in 1 June 2023.
1 June 2022
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 1 July 2021 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 June 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Chest examination with Ultrasound device
Conditions studied
- Contusions Pulmonary — all drugs for Contusions Pulmonary →
- Lung Injury — all drugs for Lung Injury →
- Chest Trauma — all drugs for Chest Trauma →
- Fluid Overload Pulmonary Edema — all drugs for Fluid Overload Pulmonary Edema →
Sponsor
Assiut University
Who can join
18 and older, any sex, with Contusions Pulmonary or Lung Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Efficacy of Lung ultrasound in monitoring fluid resuscitation in chest trauma patients with lung contusions
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05054270
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05054270 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 30 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05054270.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing